TY - JOUR AU - Renovanz, M. AU - Kim, E. L. PY - 2014 DA - 2014// TI - Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment JO - Front Oncol. VL - 4 UR - https://doi.org/10.3389/fonc.2014.00142 DO - 10.3389/fonc.2014.00142 ID - Renovanz2014 ER - TY - JOUR AU - Zhang, M. AU - Rosen, J. M. PY - 2015 DA - 2015// TI - Developmental insights into breast cancer intratumoral heterogeneity JO - Trends Cancer. VL - 1 UR - https://doi.org/10.1016/j.trecan.2015.10.005 DO - 10.1016/j.trecan.2015.10.005 ID - Zhang2015 ER - TY - JOUR AU - Martelotto, L. G. AU - Ng, C. K. AU - Piscuoglio, S. AU - Weigelt, B. AU - Reis-Filho, J. S. PY - 2014 DA - 2014// TI - Breast cancer intra-tumor heterogeneity JO - Breast Cancer Res VL - 16 UR - https://doi.org/10.1186/bcr3658 DO - 10.1186/bcr3658 ID - Martelotto2014 ER - TY - JOUR AU - Dawood, S. AU - Austin, L. AU - Cristofanilli, M. PY - 2014 DA - 2014// TI - Cancer stem cells: implications for cancer therapy JO - Oncology (Williston Park) VL - 28 ID - Dawood2014 ER - TY - JOUR AU - Ajani, J. A. AU - Song, S. AU - Hochster, H. S. AU - Steinberg, I. B. PY - 2015 DA - 2015// TI - Cancer stem cells: the promise and the potential JO - Semin Oncol VL - 42 UR - https://doi.org/10.1053/j.seminoncol.2015.01.001 DO - 10.1053/j.seminoncol.2015.01.001 ID - Ajani2015 ER - TY - JOUR AU - Angeloni, V. AU - Tiberio, P. AU - Appierto, V. AU - Daidone, M. G. PY - 2015 DA - 2015// TI - Implications of stemness-related signaling pathways in breast cancer response to therapy JO - Semin Cancer Biol VL - 31 UR - https://doi.org/10.1016/j.semcancer.2014.08.004 DO - 10.1016/j.semcancer.2014.08.004 ID - Angeloni2015 ER - TY - JOUR AU - Shao, J. AU - Fan, W. AU - Ma, B. AU - Wu, Y. PY - 2016 DA - 2016// TI - Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics JO - Mol Med Rep. VL - 14 UR - https://doi.org/10.3892/mmr.2016.5899 DO - 10.3892/mmr.2016.5899 ID - Shao2016 ER - TY - JOUR AU - Al-Hajj, M. AU - Wicha, M. S. AU - Benito-Hernandez, A. AU - Morrison, S. J. AU - Clarke, M. F. PY - 2003 DA - 2003// TI - Prospective identification of tumorigenic breast cancer cells JO - Proc Natl Acad Sci USA VL - 100 UR - https://doi.org/10.1073/pnas.0530291100 DO - 10.1073/pnas.0530291100 ID - Al-Hajj2003 ER - TY - JOUR AU - Nassar, A. AU - Radhakrishnan, A. AU - Cabrero, I. A. AU - Cotsonis, G. A. AU - Cohen, C. PY - 2010 DA - 2010// TI - Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study JO - Appl Immunohistochem Mol Morphol VL - 18 UR - https://doi.org/10.1097/PAI.0b013e3181dddb20 DO - 10.1097/PAI.0b013e3181dddb20 ID - Nassar2010 ER - TY - JOUR AU - Huebschman, M. L. AU - Lane, N. L. AU - Liu, H. AU - Sarode, V. R. AU - Devlin, J. L. AU - Frenkel, E. P. PY - 2015 DA - 2015// TI - Molecular heterogeneity in adjacent cells in triple-negative breast cancer JO - Breast Cancer (Dove Med Press). VL - 7 UR - https://doi.org/10.2147/BCTT.S87041 DO - 10.2147/BCTT.S87041 ID - Huebschman2015 ER - TY - JOUR AU - Allott, E. H. AU - Geradts, J. AU - Sun, X. AU - Cohen, S. M. AU - Zirpoli, G. R. AU - Khoury, T. PY - 2016 DA - 2016// TI - Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification JO - Breast Cancer Res VL - 18 UR - https://doi.org/10.1186/s13058-016-0725-1 DO - 10.1186/s13058-016-0725-1 ID - Allott2016 ER - TY - JOUR AU - Burke, H. B. PY - 2016 DA - 2016// TI - Predicting clinical outcomes using molecular biomarkers JO - Biomark Cancer. VL - 8 UR - https://doi.org/10.4137/BIC.S33380 DO - 10.4137/BIC.S33380 ID - Burke2016 ER - TY - JOUR AU - Bubendorf, L. AU - Nocito, A. AU - Moch, H. AU - Sauter, G. PY - 2001 DA - 2001// TI - Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies JO - J Pathol. VL - 195 UR - https://doi.org/10.1002/path.893 DO - 10.1002/path.893 ID - Bubendorf2001 ER - TY - JOUR AU - Kononen, J. AU - Bubendorf, L. AU - Kallioniemi, A. AU - Bärlund, M. AU - Schraml, P. AU - Leighton, S. PY - 1998 DA - 1998// TI - Tissue microarrays for high-throughput molecular profiling of tumor specimens JO - Nat Med VL - 4 UR - https://doi.org/10.1038/nm0798-844 DO - 10.1038/nm0798-844 ID - Kononen1998 ER - TY - BOOK AU - Lakhani, S. R. AU - Ellis, I. O. AU - Schnitt, S. J. AU - Tan, P. H. AU - Vijver, M. J. PY - 2012 DA - 2012// TI - WHO classification of tumours of the breast PB - IARC CY - Lyon ID - Lakhani2012 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. AU - Dowsett, M. AU - McShane, L. M. AU - Allison, K. H. PY - 2013 DA - 2013// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.50.9984 DO - 10.1200/JCO.2013.50.9984 ID - Wolff2013 ER - TY - JOUR AU - Dobin, A. AU - Davis, C. A. AU - Schlesinger, F. AU - Drenkow, J. AU - Zaleski, C. AU - Jha, S. PY - 2013 DA - 2013// TI - STAR: ultrafast universal RNA-seq aligner JO - Bioinformatics VL - 29 UR - https://doi.org/10.1093/bioinformatics/bts635 DO - 10.1093/bioinformatics/bts635 ID - Dobin2013 ER - TY - JOUR AU - Liao, Y. AU - Smyth, G. K. AU - Shi, W. PY - 2013 DA - 2013// TI - The subread aligner: fast, accurate and scalable read mapping by seed-and-vote JO - Nucleic Acids Res VL - 41 UR - https://doi.org/10.1093/nar/gkt214 DO - 10.1093/nar/gkt214 ID - Liao2013 ER - TY - JOUR AU - Robinson, M. D. AU - McCarthy, D. J. AU - Smyth, G. K. PY - 2010 DA - 2010// TI - edgeR: a Bioconductor package for differential expression analysis of digital gene expression data JO - Bioinformatics VL - 26 UR - https://doi.org/10.1093/bioinformatics/btp616 DO - 10.1093/bioinformatics/btp616 ID - Robinson2010 ER - TY - JOUR AU - Focke, C. M. AU - Decker, T. AU - Diest, P. J. PY - 2016 DA - 2016// TI - Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours JO - Histopathology VL - 69 UR - https://doi.org/10.1111/his.13007 DO - 10.1111/his.13007 ID - Focke2016 ER - TY - JOUR AU - Barry, W. T. AU - Kernagis, D. N. AU - Dressman, H. K. AU - Griffis, R. J. AU - Hunter, J. D. AU - Olson, J. A. PY - 2010 DA - 2010// TI - Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.7245 DO - 10.1200/JCO.2009.26.7245 ID - Barry2010 ER - TY - JOUR AU - Yang, F. AU - Cao, L. AU - Sun, Z. AU - Jin, J. AU - Fang, H. AU - Zhang, W. PY - 2016 DA - 2016// TI - Evaluation of breast cancer stem cells and intratumor stemness heterogeneity in triple-negative breast cancer as prognostic factors JO - Int J Biol Sci. VL - 12 UR - https://doi.org/10.7150/ijbs.16874 DO - 10.7150/ijbs.16874 ID - Yang2016 ER - TY - JOUR AU - Alkatout, I. AU - Wiedermann, M. AU - Bauer, M. AU - Wenners, A. AU - Jonat, W. AU - Klapper, W. PY - 2013 DA - 2013// TI - Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer JO - Exp Mol Pathol VL - 94 UR - https://doi.org/10.1016/j.yexmp.2012.09.003 DO - 10.1016/j.yexmp.2012.09.003 ID - Alkatout2013 ER - TY - JOUR AU - Sato, F. AU - Saji, S. AU - Toi, M. PY - 2016 DA - 2016// TI - Genomic tumor evolution of breast cancer JO - Breast Cancer. VL - 23 UR - https://doi.org/10.1007/s12282-015-0617-8 DO - 10.1007/s12282-015-0617-8 ID - Sato2016 ER - TY - JOUR AU - Tomaskovic-Crook, E. AU - Thompson, E. W. AU - Thiery, J. P. PY - 2009 DA - 2009// TI - Epithelial to mesenchymal transition and breast cancer JO - Breast Cancer Res VL - 11 UR - https://doi.org/10.1186/bcr2416 DO - 10.1186/bcr2416 ID - Tomaskovic-Crook2009 ER - TY - JOUR AU - Liu, H. AU - Zhang, X. AU - Li, J. AU - Sun, B. AU - Qian, H. AU - Yin, Z. PY - 2015 DA - 2015// TI - The biological and clinical importance of epithelial–mesenchymal transition in circulating tumor cells JO - J Cancer Res Clin Oncol VL - 141 UR - https://doi.org/10.1007/s00432-014-1752-x DO - 10.1007/s00432-014-1752-x ID - Liu2015 ER - TY - JOUR AU - Mego, M. AU - Mani, S. A. AU - Lee, B. N. AU - Li, C. AU - Evans, K. W. AU - Cohen, E. N. PY - 2012 DA - 2012// TI - Expression of epithelial–mesenchymal transition-inducing transcription factors in primary breast cancer: the effect of neoadjuvant therapy JO - Int J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.26037 DO - 10.1002/ijc.26037 ID - Mego2012 ER - TY - JOUR AU - Choi, Y. AU - Lee, H. J. AU - Jang, M. H. AU - Gwak, J. M. AU - Lee, K. S. AU - Kim, E. J. PY - 2013 DA - 2013// TI - Epithelial–mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer JO - Hum Pathol VL - 44 UR - https://doi.org/10.1016/j.humpath.2013.07.003 DO - 10.1016/j.humpath.2013.07.003 ID - Choi2013 ER - TY - JOUR AU - Wu, Y. AU - Sarkissyan, M. AU - Vadgama, J. V. PY - 2016 DA - 2016// TI - Epithelial–mesenchymal transition and breast cancer JO - J Clin Med. UR - https://doi.org/10.3390/jcm5020013 DO - 10.3390/jcm5020013 ID - Wu2016 ER - TY - JOUR AU - Anwar, T. E. AU - Kleer, C. G. PY - 2013 DA - 2013// TI - Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer JO - Hum Pathol VL - 44 UR - https://doi.org/10.1016/j.humpath.2013.01.005 DO - 10.1016/j.humpath.2013.01.005 ID - Anwar2013 ER - TY - JOUR AU - Brabletz, T. AU - Jung, A. AU - Reu, S. AU - Porzner, M. AU - Hlubek, F. AU - Kunz-Schughart, L. A. PY - 2001 DA - 2001// TI - Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment JO - Proc Natl Acad Sci USA VL - 98 UR - https://doi.org/10.1073/pnas.171610498 DO - 10.1073/pnas.171610498 ID - Brabletz2001 ER - TY - JOUR AU - Connor, A. J. M. AU - Pinder, S. E. AU - Elston, C. W. AU - Bell, J. A. AU - Wencyk, P. AU - Robertson, J. F. R. PY - 1997 DA - 1997// TI - Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody JO - Breast VL - 6 UR - https://doi.org/10.1016/S0960-9776(97)90568-3 DO - 10.1016/S0960-9776(97)90568-3 ID - Connor1997 ER - TY - JOUR AU - Patani, N. AU - Martin, L. A. AU - Dowsett, M. PY - 2013 DA - 2013// TI - Biomarkers for the clinical management of breast cancer: international perspective JO - Int J Cancer VL - 133 UR - https://doi.org/10.1002/ijc.27997 DO - 10.1002/ijc.27997 ID - Patani2013 ER - TY - JOUR AU - Aleskandarany, M. A. AU - Soria, D. AU - Green, A. R. AU - Nolan, C. AU - Diez-Rodriguez, M. AU - Ellis, I. O. PY - 2015 DA - 2015// TI - Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification JO - Breast Cancer Res Treat VL - 151 UR - https://doi.org/10.1007/s10549-015-3406-3 DO - 10.1007/s10549-015-3406-3 ID - Aleskandarany2015 ER - TY - JOUR AU - Matsumoto, A. AU - Jinno, H. AU - Ando, T. AU - Fujii, T. AU - Nakamura, T. AU - Saito, J. PY - 2016 DA - 2016// TI - Biological markers of invasive breast cancer JO - Jpn J Clin Oncol VL - 46 UR - https://doi.org/10.1093/jjco/hyv153 DO - 10.1093/jjco/hyv153 ID - Matsumoto2016 ER - TY - JOUR AU - Cidado, J. AU - Wong, H. Y. AU - Rosen, D. M. AU - Cimino-Mathews, A. AU - Garay, J. P. AU - Fessler, A. G. PY - 2016 DA - 2016// TI - Ki-67 is required for maintenance of cancer stem cells but not cell proliferation JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.7057 DO - 10.18632/oncotarget.7057 ID - Cidado2016 ER - TY - JOUR AU - Shokouh, T. Z. AU - Ezatollah, A. AU - Barand, P. PY - 2015 DA - 2015// TI - Interrelationships between Ki67, HER2/neu, p53, ER, and PR status and their associations with tumor grade and lymph node involvement in breast carcinoma subtypes: retrospective-observational analytical study JO - Medicine (Baltimore). VL - 94 UR - https://doi.org/10.1097/MD.0000000000001359 DO - 10.1097/MD.0000000000001359 ID - Shokouh2015 ER - TY - JOUR AU - Razis, E. AU - Bobos, M. AU - Kotoula, V. AU - Eleftheraki, A. G. AU - Kalofonos, H. P. AU - Pavlakis, K. PY - 2011 DA - 2011// TI - Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer JO - Breast Cancer Res Treat VL - 128 UR - https://doi.org/10.1007/s10549-011-1572-5 DO - 10.1007/s10549-011-1572-5 ID - Razis2011 ER - TY - JOUR AU - Lebok, P. AU - Kopperschmidt, V. AU - Kluth, M. AU - Hube-Magg, C. AU - Özden, C. PY - 2015 DA - 2015// TI - Partial PTEN deletion is linked to poor prognosis in breast cancer JO - BMC Cancer. VL - 15 UR - https://doi.org/10.1186/s12885-015-1770-3 DO - 10.1186/s12885-015-1770-3 ID - Lebok2015 ER - TY - JOUR AU - Abraham, B. K. AU - Fritz, P. AU - McClellan, M. AU - Hauptvogel, P. AU - Athelogou, M. AU - Brauch, H. PY - 2005 DA - 2005// TI - Prevalence of CD44 +/CD24 −/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis JO - Clin Cancer Res VL - 11 ID - Abraham2005 ER - TY - JOUR AU - Mylona, E. AU - Giannopoulou, I. AU - Fasomytakis, E. AU - Nomikos, A. AU - Magkou, C. AU - Bakarakos, P. PY - 2008 DA - 2008// TI - The clinicopathologic and prognostic significance of CD44 +/CD24(−/low) and CD44 −/CD24 + tumor cells in invasive breast carcinomas JO - Hum Pathol VL - 39 UR - https://doi.org/10.1016/j.humpath.2007.12.003 DO - 10.1016/j.humpath.2007.12.003 ID - Mylona2008 ER - TY - JOUR AU - Honeth, G. AU - Bendahl, P. O. AU - Ringnér, M. AU - Saal, L. H. AU - Gruvberger-Saal, S. K. AU - Lövgren, K. PY - 2008 DA - 2008// TI - The CD44 +/CD24 − phenotype is enriched in basal-like breast tumors JO - Breast Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr2108 DO - 10.1186/bcr2108 ID - Honeth2008 ER - TY - JOUR AU - Collina, F. AU - Bonito, M. AU - Li Bergolis, V. AU - Laurentiis, M. AU - Vitagliano, C. AU - Cerrone, M. PY - 2015 DA - 2015// TI - Prognostic value of cancer stem cells markers in triple-negative breast cancer JO - Biomed Res Int VL - 2015 UR - https://doi.org/10.1155/2015/158682 DO - 10.1155/2015/158682 ID - Collina2015 ER - TY - JOUR AU - Dan, T. AU - Hewitt, S. M. AU - Ohri, N. AU - Ly, D. AU - Soule, B. P. AU - Smith, S. L. PY - 2014 DA - 2014// TI - CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up JO - Breast Cancer Res Treat VL - 143 UR - https://doi.org/10.1007/s10549-013-2758-9 DO - 10.1007/s10549-013-2758-9 ID - Dan2014 ER - TY - JOUR AU - Diaz, L. K. AU - Zhou, X. AU - Wright, E. T. AU - Cristofanilli, M. AU - Smith, T. AU - Yang, Y. PY - 2005 DA - 2005// TI - CD44 expression is associated with increased survival in node-negative invasive breast carcinoma JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2184 DO - 10.1158/1078-0432.CCR-04-2184 ID - Diaz2005 ER - TY - JOUR AU - Kristiansen, G. AU - Winzer, K. J. AU - Mayordomo, E. AU - Bellach, J. AU - Schlüns, K. AU - Denkert, C. PY - 2003 DA - 2003// TI - CD24 expression is a new prognostic marker in breast cancer JO - Clin Cancer Res VL - 9 ID - Kristiansen2003 ER - TY - JOUR AU - Jang, M. H. AU - Kang, H. J. AU - Jang, K. S. AU - Paik, S. S. AU - Kim, W. S. PY - 2016 DA - 2016// TI - Clinicopathological analysis of CD44 and CD24 expression in invasive breast cancer JO - Oncol Lett. VL - 12 UR - https://doi.org/10.3892/ol.2016.4987 DO - 10.3892/ol.2016.4987 ID - Jang2016 ER - TY - JOUR AU - Inoue, K. AU - Fry, E. A. PY - 2016 DA - 2016// TI - Novel molecular markers for breast cancer JO - Biomark Cancer. VL - 8 UR - https://doi.org/10.4137/BIC.S38394 DO - 10.4137/BIC.S38394 ID - Inoue2016 ER - TY - JOUR AU - Chakravarty, G. AU - Moroz, K. AU - Makridakis, N. M. AU - Lloyd, S. A. AU - Galvez, S. E. AU - Canavello, P. R. PY - 2011 DA - 2011// TI - Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer JO - Exp Biol Med (Maywood). VL - 236 UR - https://doi.org/10.1258/ebm.2010.010086 DO - 10.1258/ebm.2010.010086 ID - Chakravarty2011 ER - TY - JOUR AU - Guo, W. AU - Keckesova, Z. AU - Donaher, J. L. AU - Shibue, T. AU - Tischler, V. AU - Reinhardt, F. PY - 2012 DA - 2012// TI - Slug and Sox9 cooperatively determine the mammary stem cell state JO - Cell VL - 148 UR - https://doi.org/10.1016/j.cell.2012.02.008 DO - 10.1016/j.cell.2012.02.008 ID - Guo2012 ER - TY - JOUR AU - Riemenschnitter, C. AU - Teleki, I. AU - Tischler, V. AU - Guo, W. AU - Varga, Z. PY - 2013 DA - 2013// TI - Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy JO - Springerplus. VL - 2 UR - https://doi.org/10.1186/2193-1801-2-695 DO - 10.1186/2193-1801-2-695 ID - Riemenschnitter2013 ER - TY - JOUR AU - Markiewicz, A. AU - Ahrends, T. AU - Wełnicka-Jaśkiewicz, M. AU - Seroczyńska, B. AU - Skokowski, J. AU - Jaśkiewicz, J. PY - 2012 DA - 2012// TI - Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer JO - J Transl Med. VL - 10 UR - https://doi.org/10.1186/1479-5876-10-226 DO - 10.1186/1479-5876-10-226 ID - Markiewicz2012 ER - TY - JOUR AU - Ren, H. AU - Du, P. AU - Ge, Z. AU - Jin, Y. AU - Ding, D. AU - Liu, X. PY - 2016 DA - 2016// TI - TWIST1 and BMI1 in cancer metastasis and chemoresistance JO - J Cancer. VL - 7 UR - https://doi.org/10.7150/jca.14031 DO - 10.7150/jca.14031 ID - Ren2016 ER - TY - JOUR AU - Zhang, Y. Q. AU - Wei, X. L. AU - Liang, Y. K. AU - Chen, W. L. AU - Zhang, F. AU - Bai, J. W. PY - 2015 DA - 2015// TI - Over-expressed twist associates with markers of epithelial mesenchymal transition and predicts poor prognosis in breast cancers via erk and Akt activation JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0135851 DO - 10.1371/journal.pone.0135851 ID - Zhang2015 ER - TY - JOUR AU - Pomp, V. AU - Leo, C. AU - Mauracher, A. AU - Korol, D. AU - Guo, W. AU - Varga, Z. PY - 2015 DA - 2015// TI - Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer JO - Breast Cancer Res Treat VL - 154 UR - https://doi.org/10.1007/s10549-015-3598-6 DO - 10.1007/s10549-015-3598-6 ID - Pomp2015 ER - TY - JOUR AU - Li, Z. AU - Yin, S. AU - Zhang, L. AU - Liu, W. AU - Chen, B. PY - 2017 DA - 2017// TI - Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis JO - Oncotarget. UR - https://doi.org/10.18632/oncotarget.14860 DO - 10.18632/oncotarget.14860 ID - Li2017 ER - TY - JOUR AU - Shamir, E. R. AU - Ewald, A. J. PY - 2015 DA - 2015// TI - Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration JO - Curr Top Dev Biol VL - 112 UR - https://doi.org/10.1016/bs.ctdb.2014.12.001 DO - 10.1016/bs.ctdb.2014.12.001 ID - Shamir2015 ER - TY - JOUR AU - Huang, Y. H. AU - Luo, M. H. AU - Ni, Y. B. AU - Tsang, J. Y. AU - Chan, S. K. AU - Lui, P. C. PY - 2014 DA - 2014// TI - Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases JO - Histopathology VL - 64 UR - https://doi.org/10.1111/his.12257 DO - 10.1111/his.12257 ID - Huang2014 ER - TY - JOUR AU - Ding, X. F. AU - Li, L. F. AU - Zhou, X. L. AU - Guo, L. N. AU - Dou, M. M. AU - Chi, Y. Y. PY - 2017 DA - 2017// TI - P-mTOR expression and implication in breast carcinoma: a systematic review and meta-analysis JO - PLoS ONE VL - 12 UR - https://doi.org/10.1371/journal.pone.0170302 DO - 10.1371/journal.pone.0170302 ID - Ding2017 ER - TY - JOUR AU - Sobottka, B. AU - Pestalozzi, B. AU - Fink, D. AU - Moch, H. AU - Varga, Z. PY - 2016 DA - 2016// TI - Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastases JO - Oncoimmunology. VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1153208 DO - 10.1080/2162402X.2016.1153208 ID - Sobottka2016 ER - TY - JOUR AU - Payandeh, M. AU - Shahriari-Ahmadi, A. AU - Sadeghi, M. AU - Sadeghi, E. PY - 2016 DA - 2016// TI - Correlations between HER2 expression and other prognostic factors in breast cancer: inverse relations with the Ki-67 index and P53 status JO - Asian Pac J Cancer Prev VL - 17 UR - https://doi.org/10.7314/APJCP.2016.17.3.1015 DO - 10.7314/APJCP.2016.17.3.1015 ID - Payandeh2016 ER - TY - JOUR AU - Rosa, F. E. AU - Caldeira, J. R. F. AU - Felipes, J. AU - Bertonha, F. B. AU - Quevedo, F. C. AU - Domingues, M. A. C. PY - 2008 DA - 2008// TI - Evaluation of estrogen receptor α and β and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers JO - Hum Pathol VL - 39 UR - https://doi.org/10.1016/j.humpath.2007.09.019 DO - 10.1016/j.humpath.2007.09.019 ID - Rosa2008 ER - TY - JOUR AU - Adamczyk, A. AU - Niemiec, J. AU - Janecka, A. AU - Harazin-Lechowska, A. AU - Ambicka, A. AU - Grela-Wojewoda, A. PY - 2015 DA - 2015// TI - Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting JO - Pol J Pathol VL - 66 UR - https://doi.org/10.5114/pjp.2015.53009 DO - 10.5114/pjp.2015.53009 ID - Adamczyk2015 ER - TY - JOUR AU - Sueta, A. AU - Yamamoto, Y. AU - Yamamoto-Ibusuki, M. AU - Hayashi, M. AU - Takeshita, T. AU - Yamamoto, S. PY - 2014 DA - 2014// TI - An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0116054 DO - 10.1371/journal.pone.0116054 ID - Sueta2014 ER - TY - JOUR AU - Li, Y. AU - Wu, Y. AU - Abbatiello, T. C. AU - Wu, W. L. AU - Kim, J. R. AU - Sarkissyan, M. PY - 2015 DA - 2015// TI - Slug contributes to cancer progression by direct regulation of ERα signaling pathway JO - Int J Oncol VL - 46 UR - https://doi.org/10.3892/ijo.2015.2878 DO - 10.3892/ijo.2015.2878 ID - Li2015 ER -